FDA Inspection 1033814 — Takeda Pharmaceutical Company Limited
The FDA completed an inspection of Takeda Pharmaceutical Company Limited on Nov 7, 2017 in Hikari. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hikari (Japan)